CLARK IAN T Insider Trading Activity (OLMA)

Summary

Updated Jul 16, 2026

CLARK IAN T has filed 6 SEC Form 4 filings across 5 companies in the last 90 days — selling. Lifetime open-market sales: $980K.

Profile

Ian T. Clark is a corporate executive and director known for his roles in various biotechnology companies, including BioMarin Pharmaceutical Inc. He has experience in the pharmaceutical industry and has contributed to the development of therapies for rare genetic diseases.

Role	Insider
Notability	30/100

Board memberships

GoodRx Holdings, Inc.
BioMarin Pharmaceutical Inc.
Guardant Health, Inc.

Awards & honors

Director at BioMarin Pharmaceutical
Experience in biotechnology sector
Contributions to rare disease therapies

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-22	GH	Guardant Health, Inc.	M — Option exercise	5.1K	$0.00
2026-06-04	BMRN	BIOMARIN PHARMACEUTICAL INC	A — Grant or award	7.5K	$0.00
2026-05-29	KYTX	Kyverna Therapeutics, Inc.	A — Grant or award	5.1K	$0.00
2026-05-22	GH	Guardant Health, Inc.	S — Open-market sale	6.9K	$106.90	$735K
2025-08-01	BMRN	BIOMARIN PHARMACEUTICAL INC	A — Grant or award	7.0K	$0.00
2025-07-08	GDRX	GoodRx Holdings, Inc.	M — Option exercise	17.2K	$4.74	$82K
2024-11-14	GH	Guardant Health, Inc.	J — Other acquisition / disposition	8.4K	$0.00
2024-11-14	GH	Guardant Health, Inc.	J — Other acquisition / disposition	8.4K	$0.00
2024-11-14	GH	Guardant Health, Inc.	S — Open-market sale	7.2K	$29.44	$213K
2024-11-14	GH	Guardant Health, Inc.	S — Open-market sale	1.1K	$29.52	$32K
2024-11-14	GH	Guardant Health, Inc.	M — Option exercise	1.1K	$4.18	$4K

Companies — Last 90 Days

Olema Pharmaceuticals, Inc. (OLMA) — 1 filings, last 2026-06-23
Guardant Health, Inc. (GH) — 2 filings, last 2026-06-22
Corvus Pharmaceuticals, Inc. (CRVS) — 1 filings, last 2026-06-15
BIOMARIN PHARMACEUTICAL INC (BMRN) — 1 filings, last 2026-06-04
Kyverna Therapeutics, Inc. (KYTX) — 1 filings, last 2026-05-29

Frequently Asked Questions

Who is CLARK IAN T?

How many SEC Form 4 filings has CLARK IAN T submitted recently?

6 primary Form 4 filings in the last 90 days, covering 5 companies.

Has CLARK IAN T been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($980K) across all tracked filings.

Where can I see all of CLARK IAN T's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

CLARK IAN T — SEC Form 4 Insider Trading Activity